Mélanges de peptides

Mélange GLOW (GHK-Cu + TB-500 + BPC-157)

The GLOW Blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) is a sophisticated tissue regeneration formulation activating complementary molecular pathways. GHK-Cu modulates gene expression and collagen synthesis via TGF-β. BPC-157 drives angiogenesis through VEGFR2-Akt-eNOS signaling. TB-500 orchestrates cytoskeletal dynamics through actin sequestration. Together they coordinate collagen synthesis, angiogenesis, anti-inflammatory modulation, and ECM organization. Available as lyophilized powder.

Formule moléculaire Mélange
Séquence/Composition GHK-Cu + TB-500 + BPC-157
Formulaire Poudre lyophilisée
La pureté ≥99% par HPLC

UGS disponibles

Modèle Spécifications MOQ
glow-5 5ml 1 flacon
glow-10 10ml 1 flacon
glow-20 20ml 1 flacon
Expédition dans les 3 à 5 jours ouvrables
Certificat d'analyse inclus
Qualité garantie

Aperçu du produit

The GLOW Blend embodies the principle that carefully selected peptide combinations achieve synergistic effects exceeding individual components. GHK-Cu influences approximately 31% of the human genome, resetting gene expression patterns to favor tissue repair. BPC-157 activates FAK-paxillin and VEGFR2-Akt-eNOS signaling cascades. TB-500 serves as the dominant G-actin sequestering protein, orchestrating cytoskeletal dynamics for cell migration and remodeling.

Mécanisme d'action

The three peptides activate complementary pathways: GHK-Cu drives collagen synthesis via TGF-β pathway activation (collagen production increases 70% in 12 weeks at optimal concentrations). BPC-157 upregulates VEGFR2 expression for angiogenesis. TB-500 sequesters G-actin to enable cell motility. All three suppress NF-κB for coordinated anti-inflammatory modulation.

Principaux avantages

Synergistic Collagen Synthesis — GHK-Cu activates TGF-β for collagen Types I and III production. Combined with BPC-157's vascular support and TB-500's cytoskeletal organization, newly synthesized collagen forms properly organized matrices rather than scar tissue.

Coordinated Angiogenesis — Multi-pathway vascular development: GHK-Cu upregulates VEGF/FGF-2, BPC-157 activates VEGFR2, and TB-500 mobilizes endothelial progenitor cells. Creates comprehensive vascular network formation.

Anti-Inflammatory Coordination — All three peptides suppress NF-κB through distinct mechanisms, creating a cellular environment favoring repair over continued immune activation.

Wound Healing Acceleration — Optimizes all phases of repair from hemostasis through tissue remodeling. GHK-Cu modulates metalloproteinases for dynamic matrix remodeling, preventing excessive scarring.

Références

  1. Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. *BioMed Res Int.* 2015;2015:648108.
  2. Li Y, et al. Peptides: emerging candidates for the prevention and treatment of skin senescence. *Int J Mol Sci.* 2025;26(2):564.
  3. Sosne G, et al. Thymosin beta 4 promotes dermal wound repair in diabetic and aged mice. *Wound Repair Regen.* 2002;10(6):369–374.

Support technique

Notre équipe est disponible 24 heures sur 24, 7 jours sur 7, pour répondre aux questions sur les produits et fournir une assistance technique.

Support de contact

Services OEM

Besoin de modifications ou de plus grandes quantités ? Contactez-nous pour un devis personnalisé.

Demande sur mesure
Formule moléculaire Mélange
Séquence/Composition GHK-Cu + TB-500 + BPC-157
Formulaire Poudre lyophilisée
La pureté ≥99% par HPLC
Stockage -20°C desséché

Besoin d'un OEM ou d'une configuration personnalisée ?

Nous proposons des synthèses sur mesure, des modifications et des services OEM. Faites-nous part de vos exigences, notamment en matière de séquence, de pureté, de quantité et de besoins particuliers. Notre équipe vous fournira un devis détaillé.